WATA CHEMICALS LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 138.1 BDT | +0.07% |
|
+6.64% | -31.02% |
Valuation
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,912 | 5,771 | 4,665 | 4,107 | 3,174 | 2,967 |
| Enterprise Value (EV) 1 | 3,597 | 6,882 | 6,101 | 5,643 | 4,952 | 4,779 |
| P/E ratio | 55.8 x | 41.8 x | 39.1 x | 45.2 x | 52.9 x | 66 x |
| Yield | 0.41% | 0.62% | 1.11% | 1.08% | 0.93% | 0.75% |
| Capitalization / Revenue | 6.85 x | 6.62 x | 6.05 x | 7.21 x | 3.33 x | 2.94 x |
| EV / Revenue | 8.46 x | 7.89 x | 7.92 x | 9.9 x | 5.19 x | 4.73 x |
| EV / EBITDA | 29.5 x | 23.9 x | 20.6 x | 25.5 x | 17.8 x | 17.5 x |
| EV / FCF | -17.6 x | -7.36 x | -20.1 x | 20.5 x | -24.8 x | 1,167 x |
| FCF Yield | -5.7% | -13.6% | -4.96% | 4.88% | -4.04% | 0.09% |
| Price to Book | 4.17 x | 7.28 x | 5.33 x | 4.6 x | 3.5 x | 3.2 x |
| Nbr of stocks (in thousands) | 14,823 | 14,823 | 14,823 | 14,823 | 14,823 | 14,823 |
| Reference price 2 | 196.4 | 389.4 | 314.7 | 277.1 | 214.1 | 200.2 |
| Announcement Date | 10/29/19 | 10/29/19 | 10/29/20 | 12/2/21 | 12/29/22 | 11/5/23 |
1BDT in Million2BDT
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 425 | 872.4 | 770.5 | 569.8 | 953.8 | 1,011 |
| EBITDA 1 | 121.8 | 287.4 | 296.1 | 220.9 | 278.1 | 272.8 |
| EBIT 1 | 98.73 | 253.4 | 237.1 | 169.5 | 229.2 | 228.1 |
| Operating Margin | 23.23% | 29.05% | 30.77% | 29.76% | 24.03% | 22.56% |
| Earnings before Tax (EBT) 1 | 62.79 | 187.4 | 170.2 | 98.05 | 80.88 | 52.49 |
| Net income 1 | 52.22 | 138 | 119.3 | 90.96 | 59.96 | 44.99 |
| Net margin | 12.29% | 15.81% | 15.49% | 15.96% | 6.29% | 4.45% |
| EPS 2 | 3.523 | 9.308 | 8.050 | 6.136 | 4.045 | 3.035 |
| Free Cash Flow 1 | -204.9 | -935.6 | -302.8 | 275.3 | -199.8 | 4.094 |
| FCF margin | -48.21% | -107.24% | -39.31% | 48.31% | -20.95% | 0.4% |
| FCF Conversion (EBITDA) | - | - | - | 124.6% | - | 1.5% |
| FCF Conversion (Net income) | - | - | - | 302.62% | - | 9.1% |
| Dividend per Share 2 | 0.8000 | 2.400 | 3.500 | 3.000 | 2.000 | 1.500 |
| Announcement Date | 10/29/19 | 10/29/19 | 10/29/20 | 12/2/21 | 12/29/22 | 11/5/23 |
1BDT in Million2BDT
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 685 | 1,110 | 1,436 | 1,535 | 1,779 | 1,811 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 5.625 x | 3.863 x | 4.849 x | 6.949 x | 6.396 x | 6.639 x |
| Free Cash Flow 1 | -205 | -936 | -303 | 275 | -200 | 4.09 |
| ROE (net income / shareholders' equity) | 7.61% | 18.5% | 14.3% | 10.3% | 6.66% | 4.91% |
| ROA (Net income/ Total Assets) | 4.23% | 8.49% | 6.46% | 4.15% | 5.24% | 4.98% |
| Assets 1 | 1,233 | 1,626 | 1,848 | 2,191 | 1,145 | 903.3 |
| Book Value Per Share 2 | 47.10 | 53.50 | 59.00 | 60.20 | 61.20 | 62.50 |
| Cash Flow per Share 2 | 0.0500 | 0.0700 | 0.5300 | 2.120 | 0.7500 | 0.4200 |
| Capex 1 | 210 | 583 | 177 | 110 | 61.6 | 126 |
| Capex / Sales | 49.49% | 66.85% | 23.01% | 19.38% | 6.46% | 12.43% |
| Announcement Date | 10/29/19 | 10/29/19 | 10/29/20 | 12/2/21 | 12/29/22 | 11/5/23 |
1BDT in Million2BDT
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -31.02% | 18.65M | |
| +3.28% | 102B | |
| -2.28% | 65.53B | |
| +46.19% | 41.76B | |
| +19.68% | 38.66B | |
| +4.90% | 32.28B | |
| +9.53% | 19.57B | |
| +15.64% | 16.77B | |
| +21.26% | 15.08B | |
| +11.59% | 14.83B |
- Stock Market
- Equities
- WATACHEM Stock
- Financials Wata Chemicals Limited